Background: Patients missing scheduled appointments, or no-shows, is a pervasive issue across outpatient clinics. The estimated no-show rate among primary care clinics ranges between 14% and 50%. No-shows are estimated to cost the US healthcare system $150 billion a year. At many clinics no-shows have necessitated overbooking clinic slots to maintain efficiency. Ultimately, patient no-shows and the overbooking they necessitate causes problems for both the patient and provider.

Methods: We used the PDSA (plan/do/study/act) cycle from quality improvement methodology. We determined the baseline no-show rate at the Parkland Diabetes Clinic, an endocrinology clinic with 16 providers (including specialists and advance practice providers) which sees ∼1200 visits a month. The baseline no-show rate from June 2018 to May 20was ∼31.9% ± 2.19. We then examined clinic processes to determine reasons for no-shows through process mapping and root cause analysis. Mapping of the scheduling process identified process inefficiencies. Phone call surveys were conducted with patients with high no-show rates. Using the process map and survey data, we brainstormed interventions to target root causes of no-shows. Our first intervention was ensuring that every patient received a phone call reminder for their appointment. Our second intervention was limiting the degree to which a third-party call center handled scheduling for the Diabetes clinic.

Results: Interventions were implemented in August 2020, and subsequent data collected from November 2020 to October 2021 was analyzed to see changes in the no-show rate. The average no-show rate during this post-intervention period was ∼22.2% ± 2.50 (t-test, p <0.05) , a significant decrease from the baseline rate of ∼31.9% ± 2.19. We predict this reduction will result in more consistent follow-up care, less risk of disease progression, and increased clinical efficiency. Our next step will be to transition our interventions into long-term sustainable solutions to maintain the lower no-show rate.

Disclosure

F.Jafri: None. U.Gunasekaran: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.